annual CFF:
-$218.20M+$207.45M(+48.74%)Summary
- As of today (September 14, 2025), BIO annual cash flow from financing activities is -$218.20 million, with the most recent change of +$207.45 million (+48.74%) on December 31, 2024.
- During the last 3 years, BIO annual CFF has fallen by -$162.77 million (-293.66%).
- BIO annual CFF is now -122.41% below its all-time high of $973.58 million, reached on December 31, 2022.
Performance
BIO Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$136.30M-$38.60M(-39.51%)Summary
- As of today (September 14, 2025), BIO quarterly cash flow from financing activities is -$136.30 million, with the most recent change of -$38.60 million (-39.51%) on June 30, 2025.
- Over the past year, BIO quarterly CFF has dropped by -$39.71 million (-41.12%).
- BIO quarterly CFF is now -111.45% below its all-time high of $1.19 billion, reached on March 31, 2022.
Performance
BIO quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$356.25M-$39.71M(-12.55%)Summary
- As of today (September 14, 2025), BIO TTM cash flow from financing activities is -$356.25 million, with the most recent change of -$39.71 million (-12.55%) on June 30, 2025.
- Over the past year, BIO TTM CFF has dropped by -$33.08 million (-10.24%).
- BIO TTM CFF is now -130.13% below its all-time high of $1.18 billion, reached on March 31, 2022.
Performance
BIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIO Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.7% | -41.1% | -10.2% |
| 3 y3 years | -293.7% | -12.3% | -133.7% |
| 5 y5 years | -858.8% | -4475.4% | -221.3% |
BIO Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.4% | +48.7% | -3263.2% | +32.8% | -133.5% | +17.0% |
| 5 y | 5-year | -122.4% | +58.3% | -111.5% | +67.7% | -130.1% | +31.9% |
| alltime | all time | -122.4% | +58.3% | -111.5% | +67.7% | -130.1% | +31.9% |
BIO Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$136.30M(+39.5%) | -$356.25M(+12.5%) |
| Mar 2025 | - | -$97.70M(+272.0%) | -$316.54M(+45.1%) |
| Dec 2024 | -$218.20M(-48.7%) | -$26.27M(-72.6%) | -$218.20M(-44.4%) |
| Sep 2024 | - | -$95.99M(-0.6%) | -$392.56M(+21.5%) |
| Jun 2024 | - | -$96.59M(<-9900.0%) | -$323.17M(-24.7%) |
| Mar 2024 | - | $638.00K(-100.3%) | -$429.32M(+0.9%) |
| Dec 2023 | -$425.65M(-143.7%) | -$200.62M(+654.3%) | -$425.65M(+36.6%) |
| Sep 2023 | - | -$26.60M(-86.9%) | -$311.65M(+6.1%) |
| Jun 2023 | - | -$202.74M(-4805.0%) | -$293.82M(+38.3%) |
| Mar 2023 | - | $4.31M(-105.0%) | -$212.41M(-121.8%) |
| Dec 2022 | $973.58M(-1856.4%) | -$86.62M(+887.4%) | $973.58M(-8.6%) |
| Sep 2022 | - | -$8.77M(-92.8%) | $1.06B(+0.6%) |
| Jun 2022 | - | -$121.33M(-110.2%) | $1.06B(-10.5%) |
| Mar 2022 | - | $1.19B(>+9900.0%) | $1.18B(-2232.8%) |
| Dec 2021 | -$55.43M(-89.4%) | $4.63M(-129.7%) | -$55.43M(-88.5%) |
| Sep 2021 | - | -$15.58M(-643.9%) | -$481.95M(+3.4%) |
| Jun 2021 | - | $2.87M(-106.1%) | -$465.93M(-1.2%) |
| Mar 2021 | - | -$47.35M(-88.8%) | -$471.77M(-9.8%) |
| Dec 2020 | -$523.04M(+2198.3%) | -$421.88M(<-9900.0%) | -$523.04M(+393.7%) |
| Sep 2020 | - | $439.00K(-114.7%) | -$105.94M(-4.4%) |
| Jun 2020 | - | -$2.98M(-97.0%) | -$110.87M(-10.3%) |
| Mar 2020 | - | -$98.62M(+1961.8%) | -$123.54M(+442.8%) |
| Dec 2019 | -$22.76M(-53.2%) | -$4.78M(+6.5%) | -$22.76M(-65.0%) |
| Sep 2019 | - | -$4.49M(-71.3%) | -$64.98M(+3.7%) |
| Jun 2019 | - | -$15.64M(-824.0%) | -$62.66M(+27.8%) |
| Mar 2019 | - | $2.16M(-104.6%) | -$49.03M(+0.7%) |
| Dec 2018 | -$48.68M(<-9900.0%) | -$47.00M(+2060.1%) | -$48.68M(-2663.5%) |
| Sep 2018 | - | -$2.18M(+7.9%) | $1.90M(+53.8%) |
| Jun 2018 | - | -$2.02M(-180.2%) | $1.24M(-43.4%) |
| Mar 2018 | - | $2.52M(-29.7%) | $2.18M(+540.2%) |
| Dec 2017 | $341.00K(-96.2%) | $3.58M(-225.9%) | $341.00K(-184.0%) |
| Sep 2017 | - | -$2.84M(+165.9%) | -$406.00K(-107.6%) |
| Jun 2017 | - | -$1.07M(-258.7%) | $5.33M(-43.5%) |
| Mar 2017 | - | $673.00K(-76.2%) | $9.44M(+4.6%) |
| Dec 2016 | $9.02M(+5.1%) | $2.83M(-2.3%) | $9.02M(-9.1%) |
| Sep 2016 | - | $2.90M(-4.6%) | $9.92M(+8.5%) |
| Jun 2016 | - | $3.04M(+1076.7%) | $9.14M(-0.3%) |
| Mar 2016 | - | $258.00K(-93.1%) | $9.17M(+6.9%) |
| Dec 2015 | $8.58M(-26.6%) | $3.73M(+75.6%) | $8.58M(+7.9%) |
| Sep 2015 | - | $2.12M(-30.6%) | $7.95M(-2.1%) |
| Jun 2015 | - | $3.06M(-1024.8%) | $8.12M(+3.2%) |
| Mar 2015 | - | -$331.00K(-110.7%) | $7.87M(-32.7%) |
| Dec 2014 | $11.69M(-103.8%) | $3.10M(+35.4%) | $11.69M(-5.4%) |
| Sep 2014 | - | $2.29M(-18.4%) | $12.36M(-104.0%) |
| Jun 2014 | - | $2.81M(-19.5%) | -$312.34M(+0.3%) |
| Mar 2014 | - | $3.49M(-7.4%) | -$311.36M(-0.1%) |
| Dec 2013 | -$311.70M(-2576.1%) | $3.77M(-101.2%) | -$311.70M(-0.1%) |
| Sep 2013 | - | -$322.40M(-8606.7%) | -$311.95M(-2498.3%) |
| Jun 2013 | - | $3.79M(+20.4%) | $13.01M(+8.2%) |
| Mar 2013 | - | $3.15M(-10.4%) | $12.02M(-4.5%) |
| Dec 2012 | $12.59M(-105.9%) | $3.52M(+37.6%) | $12.59M(+71.5%) |
| Sep 2012 | - | $2.55M(-8.8%) | $7.34M(+7.3%) |
| Jun 2012 | - | $2.80M(-24.7%) | $6.84M(+39.6%) |
| Mar 2012 | - | $3.72M(-314.6%) | $4.90M(-102.3%) |
| Dec 2011 | -$213.56M(-193.4%) | -$1.73M(-184.3%) | -$213.56M(-2302.8%) |
| Sep 2011 | - | $2.06M(+139.1%) | $9.70M(-9.1%) |
| Jun 2011 | - | $860.00K(-100.4%) | $10.67M(-17.7%) |
| Mar 2011 | - | -$214.74M(-196.9%) | $12.97M(-94.3%) |
| Dec 2010 | $228.75M(-22.2%) | $221.52M(+7206.1%) | $228.75M(+2472.2%) |
| Sep 2010 | - | $3.03M(-4.0%) | $8.89M(+26.7%) |
| Jun 2010 | - | $3.16M(+205.7%) | $7.02M(-97.6%) |
| Mar 2010 | - | $1.03M(-38.1%) | $297.01M(+1.0%) |
| Dec 2009 | $293.93M(+4542.8%) | $1.67M(+44.2%) | $293.93M(-0.1%) |
| Sep 2009 | - | $1.16M(-99.6%) | $294.19M(+0.1%) |
| Jun 2009 | - | $293.15M(<-9900.0%) | $293.76M(>+9900.0%) |
| Mar 2009 | - | -$2.04M(-206.3%) | $1.50M(-76.3%) |
| Dec 2008 | $6.33M(-185.0%) | $1.92M(+162.2%) | $6.33M(-140.5%) |
| Sep 2008 | - | $733.00K(-17.4%) | -$15.63M(+19.1%) |
| Jun 2008 | - | $887.00K(-68.2%) | -$13.13M(+10.1%) |
| Mar 2008 | - | $2.79M(-113.9%) | -$11.93M(+60.1%) |
| Dec 2007 | -$7.45M(-173.0%) | -$20.04M(-719.5%) | -$7.45M(-156.3%) |
| Sep 2007 | - | $3.23M(+54.8%) | $13.23M(+1.6%) |
| Jun 2007 | - | $2.09M(-71.2%) | $13.02M(-11.8%) |
| Mar 2007 | - | $7.26M(+1038.7%) | $14.77M(+44.8%) |
| Dec 2006 | $10.20M | $638.00K(-78.9%) | $10.20M(+60.7%) |
| Sep 2006 | - | $3.03M(-21.2%) | $6.35M(+132.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2006 | - | $3.84M(+42.4%) | $2.73M(+129.5%) |
| Mar 2006 | - | $2.70M(-183.9%) | $1.19M(-7.7%) |
| Dec 2005 | $1.29M(-99.3%) | -$3.21M(+445.5%) | $1.29M(-99.4%) |
| Sep 2005 | - | -$589.00K(-125.6%) | $204.24M(+4.7%) |
| Jun 2005 | - | $2.30M(-17.8%) | $195.07M(-0.5%) |
| Mar 2005 | - | $2.79M(-98.6%) | $196.05M(+1.5%) |
| Dec 2004 | $193.23M(+78.6%) | $199.73M(-2146.9%) | $193.23M(-3677.6%) |
| Sep 2004 | - | -$9.76M(-397.8%) | -$5.40M(-104.8%) |
| Jun 2004 | - | $3.28M(<-9900.0%) | $112.69M(+1.9%) |
| Mar 2004 | - | -$24.00K(-102.2%) | $110.56M(+2.2%) |
| Dec 2003 | $108.17M(-238.3%) | $1.10M(-99.0%) | $108.17M(+51.4%) |
| Sep 2003 | - | $108.34M(+9403.2%) | $71.44M(-255.4%) |
| Jun 2003 | - | $1.14M(-147.3%) | -$45.98M(-33.0%) |
| Mar 2003 | - | -$2.41M(-93.2%) | -$68.61M(-12.3%) |
| Dec 2002 | -$78.20M(+289.1%) | -$35.62M(+292.1%) | -$78.20M(+41.1%) |
| Sep 2002 | - | -$9.08M(-57.7%) | -$55.43M(+18.4%) |
| Jun 2002 | - | -$21.49M(+79.1%) | -$46.80M(+43.9%) |
| Mar 2002 | - | -$12.00M(-6.6%) | -$32.52M(+61.8%) |
| Dec 2001 | -$20.10M(-51.7%) | -$12.85M(+2736.4%) | -$20.10M(+81.8%) |
| Sep 2001 | - | -$453.00K(-93.7%) | -$11.06M(-76.7%) |
| Jun 2001 | - | -$7.21M(-1838.1%) | -$47.47M(-3.9%) |
| Mar 2001 | - | $415.00K(-110.9%) | -$49.38M(+18.7%) |
| Dec 2000 | -$41.61M(-122.8%) | -$3.81M(-89.7%) | -$41.61M(-127.0%) |
| Sep 2000 | - | -$36.87M(+304.3%) | $154.30M(-16.9%) |
| Jun 2000 | - | -$9.12M(-211.4%) | $185.63M(-3.4%) |
| Mar 2000 | - | $8.19M(-95.7%) | $192.13M(+5.4%) |
| Dec 1999 | $182.25M(<-9900.0%) | $192.10M(-3566.3%) | $182.25M(-1736.3%) |
| Sep 1999 | - | -$5.54M(+110.9%) | -$11.14M(-25.4%) |
| Jun 1999 | - | -$2.63M(+56.1%) | -$14.93M(+51.0%) |
| Mar 1999 | - | -$1.68M(+31.2%) | -$9.88M(+992.3%) |
| Dec 1998 | -$905.00K(-102.7%) | -$1.28M(-86.2%) | -$905.00K(-102.3%) |
| Sep 1998 | - | -$9.33M(-486.4%) | $39.19M(-16.4%) |
| Jun 1998 | - | $2.42M(-66.9%) | $46.85M(+28.4%) |
| Mar 1998 | - | $7.30M(-81.2%) | $36.50M(+8.9%) |
| Dec 1997 | $33.52M(-233.2%) | $38.81M(-2425.4%) | $33.52M(-238.6%) |
| Sep 1997 | - | -$1.67M(-79.0%) | -$24.18M(+12.9%) |
| Jun 1997 | - | -$7.94M(-284.0%) | -$21.41M(+26.2%) |
| Mar 1997 | - | $4.32M(-122.8%) | -$16.97M(-32.6%) |
| Dec 1996 | -$25.17M(+92.0%) | -$18.89M(-1817.0%) | -$25.19M(+133.2%) |
| Sep 1996 | - | $1.10M(-131.4%) | -$10.80M(-27.0%) |
| Jun 1996 | - | -$3.50M(-10.3%) | -$14.80M(-7.5%) |
| Mar 1996 | - | -$3.90M(-13.3%) | -$16.00M(+22.1%) |
| Dec 1995 | -$13.11M(-60.2%) | -$4.50M(+55.2%) | -$13.10M(-20.6%) |
| Sep 1995 | - | -$2.90M(-38.3%) | -$16.50M(-10.3%) |
| Jun 1995 | - | -$4.70M(+370.0%) | -$18.40M(-25.5%) |
| Mar 1995 | - | -$1.00M(-87.3%) | -$24.70M(-24.9%) |
| Dec 1994 | -$32.90M(+116.0%) | -$7.90M(+64.6%) | -$32.90M(-25.2%) |
| Sep 1994 | - | -$4.80M(-56.4%) | -$44.00M(-0.9%) |
| Jun 1994 | - | -$11.00M(+19.6%) | -$44.40M(+69.5%) |
| Mar 1994 | - | -$9.20M(-51.6%) | -$26.20M(+72.4%) |
| Dec 1993 | -$15.23M(-970.8%) | -$19.00M(+265.4%) | -$15.20M(-235.7%) |
| Sep 1993 | - | -$5.20M(-172.2%) | $11.20M(-1966.7%) |
| Jun 1993 | - | $7.20M(+300.0%) | -$600.00K(-154.5%) |
| Mar 1993 | - | $1.80M(-75.7%) | $1.10M(-35.3%) |
| Dec 1992 | $1.75M(-93.1%) | $7.40M(-143.5%) | $1.70M(-177.3%) |
| Sep 1992 | - | -$17.00M(-291.0%) | -$2.20M(-108.2%) |
| Jun 1992 | - | $8.90M(+270.8%) | $26.80M(+30.7%) |
| Mar 1992 | - | $2.40M(-31.4%) | $20.50M(-19.3%) |
| Dec 1991 | $25.41M(+242.6%) | $3.50M(-70.8%) | $25.40M(-0.4%) |
| Sep 1991 | - | $12.00M(+361.5%) | $25.50M(+96.2%) |
| Jun 1991 | - | $2.60M(-64.4%) | $13.00M(-5.8%) |
| Mar 1991 | - | $7.30M(+102.8%) | $13.80M(+86.5%) |
| Dec 1990 | $7.42M(+42.3%) | $3.60M(-820.0%) | $7.40M(+94.7%) |
| Sep 1990 | - | -$500.00K(-114.7%) | $3.80M(-11.6%) |
| Jun 1990 | - | $3.40M(+277.8%) | $4.30M(+377.8%) |
| Mar 1990 | - | $900.00K | $900.00K |
| Dec 1989 | $5.21M(+28.7%) | - | - |
| Dec 1988 | $4.05M(-79.1%) | - | - |
| Dec 1987 | $19.34M(+42.8%) | - | - |
| Dec 1986 | $13.54M(-617.9%) | - | - |
| Dec 1985 | -$2.62M(-575.5%) | - | - |
| Dec 1984 | $550.00K(-95.9%) | - | - |
| Dec 1983 | $13.54M(-4081.8%) | - | - |
| Dec 1982 | -$340.00K(-1.4%) | - | - |
| Dec 1981 | -$345.00K(-102.9%) | - | - |
| Dec 1980 | $11.78M | - | - |
FAQ
- What is Bio-Rad Laboratories, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. annual CFF year-on-year change?
- What is Bio-Rad Laboratories, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. quarterly CFF year-on-year change?
- What is Bio-Rad Laboratories, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. TTM CFF year-on-year change?
What is Bio-Rad Laboratories, Inc. annual cash flow from financing activities?
The current annual CFF of BIO is -$218.20M
What is the all time high annual CFF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high annual cash flow from financing activities is $973.58M
What is Bio-Rad Laboratories, Inc. annual CFF year-on-year change?
Over the past year, BIO annual cash flow from financing activities has changed by +$207.45M (+48.74%)
What is Bio-Rad Laboratories, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of BIO is -$136.30M
What is the all time high quarterly CFF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high quarterly cash flow from financing activities is $1.19B
What is Bio-Rad Laboratories, Inc. quarterly CFF year-on-year change?
Over the past year, BIO quarterly cash flow from financing activities has changed by -$39.71M (-41.12%)
What is Bio-Rad Laboratories, Inc. TTM cash flow from financing activities?
The current TTM CFF of BIO is -$356.25M
What is the all time high TTM CFF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high TTM cash flow from financing activities is $1.18B
What is Bio-Rad Laboratories, Inc. TTM CFF year-on-year change?
Over the past year, BIO TTM cash flow from financing activities has changed by -$33.08M (-10.24%)